Literature DB >> 21098983

Depression and Alzheimer's disease: is stress the initiating factor in a common neuropathological cascade?

Susana Aznar1, Gitte M Knudsen.   

Abstract

The existence of a high co-morbidity between Alzheimer's disease (AD) and depression has been known for a long time. More interesting though are recent studies indicating that depression and number of depressive episodes earlier in life is associated with increased risk of AD development. This suggests the existence of common neuropathological mechanisms behind depression and AD. Here we propose that the brain changes associated with depressive episodes that compromise the brain's ability to cope with stress may constitute risk factors for development of AD. Furthermore, in individuals with a genetic linkage to depression, there may be an increased vulnerability towards the initiation of a detrimental neurodegenerative cascade. The following review will deal with the various observations reported within the different neurobiological systems known to be involved and affected in depression, like serotonergic and cholinergic system, hypothalamic-pituitary-adrenal axis and brain derived neurotrophic factor, and discussed in relation to AD.

Entities:  

Mesh:

Year:  2011        PMID: 21098983     DOI: 10.3233/JAD-2010-100390

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  32 in total

Review 1.  Antioxidants as antidepressants: fact or fiction?

Authors:  Giovanni Scapagnini; Sergio Davinelli; Filippo Drago; Antonino De Lorenzo; Giovannangelo Oriani
Journal:  CNS Drugs       Date:  2012-06-01       Impact factor: 5.749

2.  Stress hormone leads to memory deficits and altered tau phosphorylation in a model of Alzheimer's disease.

Authors:  Yash B Joshi; Jin Chu; Domenico Praticò
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

3.  A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease.

Authors:  Yoshihiro Kashiwaya; Christian Bergman; Jong-Hwan Lee; Ruiqian Wan; M Todd King; Mohamed R Mughal; Eitan Okun; Kieran Clarke; Mark P Mattson; Richard L Veech
Journal:  Neurobiol Aging       Date:  2012-12-29       Impact factor: 4.673

4.  Linkage analysis for plasma amyloid beta levels in persons with hypertension implicates Aβ-40 levels to presenilin 2.

Authors:  Carla A Ibrahim-Verbaas; Irina V Zorkoltseva; Najaf Amin; Maaike Schuur; Antonia M W Coppus; Aaron Isaacs; Yurii S Aulchenko; Monique M B Breteler; M Arfan Ikram; Tatiana I Axenovich; Marcel M Verbeek; John C van Swieten; Ben A Oostra; Cornelia M van Duijn
Journal:  Hum Genet       Date:  2012-08-08       Impact factor: 4.132

5.  Maternal dexamethasone exposure ameliorates cognition and tau pathology in the offspring of triple transgenic AD mice.

Authors:  A Di Meco; Y B Joshi; E Lauretti; D Praticò
Journal:  Mol Psychiatry       Date:  2015-06-16       Impact factor: 15.992

6.  Depressive, functional status, and neuropsychiatric symptom trajectories before an Alzheimer's disease diagnosis.

Authors:  Joseph E Gaugler; Martha Hovater; David L Roth; Joseph A Johnston; Robert L Kane; Khaled Sarsour
Journal:  Aging Ment Health       Date:  2013-07-04       Impact factor: 3.658

7.  Linking major depression and the neural substrates of associative processing.

Authors:  Eiran Vadim Harel; Robert Langley Tennyson; Maurizio Fava; Moshe Bar
Journal:  Cogn Affect Behav Neurosci       Date:  2016-12       Impact factor: 3.282

8.  Comprehensive gene- and pathway-based analysis of depressive symptoms in older adults.

Authors:  Kwangsik Nho; Vijay K Ramanan; Emrin Horgusluoglu; Sungeun Kim; Mark H Inlow; Shannon L Risacher; Brenna C McDonald; Martin R Farlow; Tatiana M Foroud; Sujuan Gao; Christopher M Callahan; Hugh C Hendrie; Alexander B Niculescu; Andrew J Saykin
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

9.  Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy.

Authors:  Jenna C Carroll; Michiyo Iba; Debra A Bangasser; Rita J Valentino; Michael J James; Kurt R Brunden; Virginia M-Y Lee; John Q Trojanowski
Journal:  J Neurosci       Date:  2011-10-05       Impact factor: 6.167

10.  Neuropsychiatric symptoms and expenditure on complementary and alternative medicine.

Authors:  Maulik P Purohit; Ross D Zafonte; Laura M Sherman; Roger B Davis; Michelle Y Giwerc; Martha E Shenton; Gloria Y Yeh
Journal:  J Clin Psychiatry       Date:  2015-07       Impact factor: 4.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.